摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Aminomethyl-3-methyl-isochinolin | 3340-31-6

中文名称
——
中文别名
——
英文名称
1-Aminomethyl-3-methyl-isochinolin
英文别名
C-(3-methyl-isoquinolin-1-yl)-methylamine;(3-methyl-isoquinolin-1-ylmethyl)amine;3-Methyl-isoquinolin-1-ylmethylamine;(3-methylisoquinolin-1-yl)methanamine
1-Aminomethyl-3-methyl-isochinolin化学式
CAS
3340-31-6
化学式
C11H12N2
mdl
——
分子量
172.23
InChiKey
AKXYQZHDMMUZDM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    38.9
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    1-Aminomethyl-3-methyl-isochinolin 在 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 作用下, 以 三乙胺N,N-二甲基甲酰胺 为溶剂, 反应 4.25h, 以78%的产率得到2-bromo-3-(2-butyn-1-yl)-5-(trans-2-methoxy-vinyl)-3H-imidazole-4-carboxylic acid-(3-methyl-isoquinolin-1-ylmethyl)-amide
    参考文献:
    名称:
    2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
    摘要:
    本发明涉及一般公式中R1至R4和X如索权1至6中定义的2-氨基咪唑并[4,5-d]吡啶并[4,5-c]吡啶-4-酮以及其互变异构体、对映异构体、非对映异构体、其混合物和盐,具有有价值的药理特性,特别是对酶二肽基肽酶-IV(DPP-IV)的抑制作用。
    公开号:
    US20050234235A1
点击查看最新优质反应信息

文献信息

  • [DE] NEUE 2-AMINO-IMIDAZO[4,5-D]PYRIDAZIN-4-ONE UND 2-AMINO-IMIDAZO[4,5-C]PYRIDIN-4-ONE, DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS ARZNEIMITTEL<br/>[EN] NOVEL 2-AMINO-IMIDAZO[4,5-D]PYRIDAZIN-4-ONES AND 2-AMINO-IMIDAZO[4,5-C]PYRIDIN-4-ONES, PRODUCTION AND USE THEREOF AS MEDICAMENTS<br/>[FR] NOUVELLES 2-AMINO-IMIDAZO[4,5-D]PYRIDAZIN-4-ONES ET 2-AMINO-IMIDAZO[4,5-C]PYRIDIN-4-ONES, LEUR PRODUCTION ET LEUR UTILISATION COMME MEDICAMENTS
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2005097798A1
    公开(公告)日:2005-10-20
    Die vorliegende Erfindung betrifft 2-Amino-imidazo[4,5-d]pyridazin-4-one und 2-Amino-imidazo[4,5-c]pyridin-4-one der allgemeinen Formel (I), in der R1 bis R4 und X wie in den Ansprüchen 1 bis 6 definiert sind, deren Tautomere, deren Enantiomere, deren Diastereomere, deren Gemische und deren Salze, welche wertvolle pharmakologische Eigenschaften aufweisen, insbesondere eine Hemmwirkung auf die Aktivität des Enzyms Dipeptidylpeptidase-IV (DPP-IV).
    这项发明涉及通式(I)中定义的R1至R4和X的2-氨基咪唑[4,5-d]吡啶嗪-4-酮和2-氨基咪唑[4,5-c]吡啶-4-酮,其咪唑异构体、对映体、二对映异构体、混合物和盐,具有有价值的药理特性,特别是对二肽基肽酶-IV(DPP-IV)活性的抑制作用。
  • 2-AMINO-IMIDAZO[4,5-D]PYRIDAZIN-4-ONES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
    申请人:Eckhardt Matthias
    公开号:US20070088038A1
    公开(公告)日:2007-04-19
    The present invention relates to 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones of general formula wherein R 1 to R 4 and X are defined as in claims 1 to 6 , the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    本发明涉及通式为的2-氨基咪唑[4,5-d]吡啶并嘧啶-4-酮和2-氨基咪唑[4,5-c]吡啶-4-酮,其中R1至R4和X如权利要求1至6所定义,其互变异构体、对映异构体、顺反异构体、混合物和盐具有有价值的药理学特性,特别是对二肽基肽酶-IV(DPP-IV)酶活性的抑制作用。
  • 2-AMINO-IMIDAZO[4,5-D]PYRIDAZIN-4-ONES, THEIR PREPARATION, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
    申请人:ECKHARDT Matthias
    公开号:US20090088569A1
    公开(公告)日:2009-04-02
    The present invention relates to 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones of general formula wherein R 1 to R 4 and X are defined as in claims 1 to 6 , the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    本发明涉及通式为的2-氨基咪唑[4,5-d]吡啶嗪-4-酮和2-氨基咪唑[4,5-c]吡啶-4-酮,其中R1至R4和X如权利要求1至6所定义,其互变异构体、对映异构体、非对映异构体、混合物及其盐具有有价值的药理学特性,特别是对酶二肽基肽酶-IV(DPP-IV)活性的抑制作用。
  • 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
    申请人:Boehringer Ingelheim International GmbH
    公开号:US07476671B2
    公开(公告)日:2009-01-13
    The present invention relates to 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones of general formula wherein R1 to R4 and X are defined as in claims 1 to 6, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    本发明涉及一般式中R1到R4和X如权利要求1至6所定义的2-氨基咪唑[4,5-d]吡啶并嘧啶-4-酮和2-氨基咪唑[4,5-c]吡啶-4-酮,其互变异构体、对映异构体、顺反异构体、其混合物和其盐,具有有价值的药理学性质,特别是对二肽基肽酶IV(DPP-IV)酶活性的抑制作用。
  • 3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: A class of potent DPP-4 inhibitors
    作者:Matthias Eckhardt、Norbert Hauel、Frank Himmelsbach、Elke Langkopf、Herbert Nar、Michael Mark、Moh Tadayyon、Leo Thomas、Brian Guth、Ralf Lotz
    DOI:10.1016/j.bmcl.2008.04.075
    日期:2008.6
    Systematic variations of the xanthine scaffold in close analogs of development compound BI 1356 led to the class of 3,5-dihydro-imidazo[4,5-d]pyridazin-4-ones which provided, after substituent screening, a series of highly potent DPP-4 inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多